Previous close | 4.4600 |
Open | 4.1400 |
Bid | 3.8000 |
Ask | 4.2500 |
Strike | 32.00 |
Expiry date | 2024-08-16 |
Day's range | 4.1300 - 4.1800 |
Contract range | N/A |
Volume | |
Open interest | 744 |
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).